Tratamiento percutáneo de la insuficiencia tricuspídea.Procedimiento detallado guiado por imagen con MitraClip

  1. Vanessa Moñivas Palomero 1
  2. Susana Mingo Santos 1
  3. Chi-Hion Li 2
  4. Laura Sanchis Ruiz 3
  5. Dabit Arzamendi 2
  6. Xavier Freixa 3
  7. Marta Sitges Carreño 3
  8. Violeta González Salvado 4
  9. Rodrigo Estévez Loureiro 5
  1. 1 Servicio de Cardiología, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, España
  2. 2 Servicio de Cardiología, Programa Cardiovascular-ICCC, Instituto de Investigación-Hospital Sant Pau i Santa Creu, CIBERCV, Barcelona, España
  3. 3 Servicio de Cardiología Instituto Cardiovascular, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, España
  4. 4 Servicio de Cardiología, Hospital Clínico Universitario de Santiago, CIBERCV, Santiago de Compostela, A Coruña, España
  5. 5 Servicio de Cardiología, Hospital Álvaro Cunqueiro, Vigo, Pontevedra, España
Show affiliations +
Journal:
REC: Interventional Cardiology

ISSN: 2604-7276,  2604-7306

Year of publication: 2020

Volume: 2

Issue: 2

Pages: 118-128

Type: Article

DOI: 10.24875/RECIC.M19000078 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: REC: Interventional Cardiology

Abstract

Severe tricuspid regurgitation is independently associated with an increased mortality. Recent studies show that surgery for isolated tricuspid valve (TV) is still associated with the highest surgical risk of all valve procedures. Percutaneous treatments for the management of tricuspid regurgitation have become an alternative to surgery in select patients of high surgical risk. To this day, the most widely used device is MitraClip in the tricuspid position. We reviewed the different devices used today for transcatheter treatments paying special attention to MitraClip. We describe the basic standpoints on transesophageal echocardiography screening and step-by-step procedure for the implantation of the clip. This document stands as a guide to systematize tricuspid valve assessments and the steps involved in device implantation to achieve successful procedures.

Bibliographic References

  • 1. Dreyfus GD, Martin RP, Chan KM, Dulguerov F, Alexandrescu C. Functional tricuspid regurgitation:a need to revise our understanding. J Am Coll Cardiol. 2015;65:2331-2336.
  • 2. Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol. 2012;59:703-710.
  • 3. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405-409.
  • 4. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7:1185-1194.
  • 5. Topilsky Y, Inojosa JM, Benfari G, et al. Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. Eur Heart J. 2018;39:3584-3592.
  • 6. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regur?gitation or dilatation:which should be the criteria for surgical repair?Ann Thorac Surg. 2005;79:127-132.
  • 7. Zack CJ, Fender EA, Chandrashekar P, et al. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017;70:2953-2960.
  • 8. Taramasso M, Alessandrini H, Latib A, et al. Outcomes After Current Transcatheter Tricuspid Valve Intervention:Mid-Term Results From the International TriValve Registry. JACC Cardiovasc Interv. 2019;12:155-165.
  • 9. Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination:recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26:921-964.
  • 10. Hahn RT. State-of-the-art review of echocardiographic imaging in the evaluation and treatment of functional tricuspid regurgitation. Circ Cardiovasc Imaging. 2016;9:e005332.
  • 11. Holda MK, Zhingre Sanchez JD, Bateman MD, Iaizo PA. Right Atrioventricular Valve Leaflet Morphology Redefined:Implications for Transcatheter Repair Procedures. JACC Cardiovasc Interv. 2019;12:169-178.
  • 12. Lang RM, Badano LP, Tsang W, et al. American Society of Echocardiography;European Association of Echocardiography. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging. 2012;13:1-46.
  • 13. Muraru D, Hanh RT, Soliman OI, et al. 3-Dimensional Echocardiography in Imaging the Tricuspid Valve. JACC Cardiovasc Imaging. 2019;12 500-515.
  • 14. Santoro C, Del Castillo AM, Gonzalez-Gomez A, et al. Mid-term outcome of severe tricuspid regurgitation:are there any differences according to mechanism and severity?Eur Heart J Cardiovasc Imaging. 2019;20:1-8.
  • 15. Nickenig G, Hausleiter J, Hahn R, et al. Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation:Primary Outcomes from the TRILUMINATE clinical trial. En:EuroPCR;2019 May 21;Paris. Disponible en:https://abstractbook.pcronline.com/export/pdf/id/110069.
  • 16. Braun D, Orban M, Orban M, et al. Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation Using the Triple-Orifice Technique Versus the Bicuspidalization Technique. JACC Cardiov Interv. 2018;11:1790-1792.
  • 17. Hausleiter J, Braun D, Orban M, et al. Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique. EuroIntervention. 2018;14:645-653.
  • 18. Besler C, Orban M, Rommel KP, et al. Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. JACC Cardiov Interv. 2018;11:1119-1128.
  • 19. Fam NP. Pascal tricuspid:early experience technology and clinical updates. En:Transcatheter Cardiovascular Therapeutics 2018;2018 Sept 23;San Diego. Disponible en:https://www.tctmd.com/slide/pascal-tricuspidearly-experience-technology-and-clinical-updates.
  • 20. Hahn RT, Meduri CU, Davidson CJ, et al. Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty:SCOUT Trial 30-Day Results. J Am Coll Cardiol. 2017;69:1795-1806.
  • 21. Nickenig G, Weber M, Schueler R, et al. 6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2019;73:1905-1915.
  • 22. Taramasso M, Latib A, Denti P, et al. Percutaneous repair of the tricuspid valve using a novel cinching device:acute and chronic experience in a preclinical large animal model. EuroIntervention. 2016;12:918-925.
  • 23. McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves:An International, Multicenter Registry Study. Circulation. 2016;133:1582-1593.
  • 24. Hahn RT, George I, Kodali SK, et al. Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement. JACC Cardiovasc Imaging. 2019;12:416-429.
Data source: Dialnet